Evidence-Based Complementary and Alternative Medicine / 2022 / Article / Tab 1 / Research Article
Chinese Herbal Medicine as an Adjunctive Therapy Improves the Survival Rate of Patients with Ischemic Heart Disease: A Nationwide Population-Based Cohort Study Table 1 Characteristics of ischemic heart disease patients according to use or nonuse of Chinese herbal medicine.
Variable Ischemic heart disease patients valueCHM users No (n = 20192, 50%) Yes (n = 20192, 50%) n % n % CHM for IHD — 376 Sex 0.99 Female 8024 39.7 8024 39.7 Male 12168 60.3 12168 60.3 Age group 0.99 20–39 878 4.35 878 4.35 40–64 9287 46.0 9287 46.0 More than 65 10027 49.7 10027 49.7 Mean ± SD (years) 63.5 (13.2) 63.4 (13.1) 0.49a Baseline comorbidity Hyperlipidemia 6275 31.1 6912 34.2 <0.001 Hypertension 12424 61.53 10496 51.98 <0.001 DM 4217 20.9 2934 14.5 <0.001 Stroke 2370 11.7 1181 5.85 <0.001 Charlson comorbidity index <0.001 0 12921 64.0 15311 75.8 1 3561 17.6 3238 16.0 2 1580 7.82 881 4.36 3+ 2130 10.6 762 3.77 Mortality 2745 13.6 1494 7.40 <0.001 Follow-up time median (IQR), years 6.00 (1.25, 6.00) 8.12 (2.77, 8.21) <0.001§
IHD: ischemic heart disease; CHM: Chinese herbal medicine; DM: diabetes mellitus; SD: standard deviation.
Chi-square test;
a t -test. IQR: interquartile range.
§ Wilcoxon’s rank-sum test.